Germany Androgenetic Alopecia Market Size & Outlook
Germany androgenetic alopecia market, 2018-2030 (US$M)
Related Markets
Germany androgenetic alopecia market highlights
- The Germany androgenetic alopecia market generated a revenue of USD 146.7 million in 2023 and is expected to reach USD 260.5 million by 2030.
- The Germany market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
- Pharmaceuticals is the most lucrative treatment segment registering the fastest growth during the forecast period.
Androgenetic alopecia market data book summary
| Market revenue in 2023 | USD 146.7 million |
| Market revenue in 2030 | USD 260.5 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Pharmaceuticals |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Devices |
| Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
Other key industry trends
- In terms of revenue, Germany accounted for 5.4% of the global androgenetic alopecia market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany androgenetic alopecia market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 181.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Androgenetic Alopecia Market Scope
Androgenetic Alopecia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany androgenetic alopecia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.43% in 2023. Horizon Databook has segmented the Germany androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The androgenetic alopecia market is mainly driven by the growing prevalence of hair loss and other medical conditions causing alopecia & hair thinning. The prevalence of AGA in Germany is highest compared to other European countries.
In addition, the growing geriatric population provides the potential target population for alopecia and anti-hair fall products. According to the World Bank data, in 2022, around 22% of the German population falls under the 65 years or above age group.
The healthcare expenditure in Germany is considered to be the highest in Europe, accounting for 12.81% of country’s GDP in 2021. Moreover, well-established healthcare infrastructure and increasing government initiatives to improve healthcare facilities facilitate market growth.
Reasons to subscribe to Germany androgenetic alopecia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany androgenetic alopecia market databook
-
Our clientele includes a mix of androgenetic alopecia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany androgenetic alopecia market , including forecasts for subscribers. This country databook contains high-level insights into Germany androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany androgenetic alopecia market size, by treatment, 2018-2030 (US$M)
Germany Androgenetic Alopecia Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
